Skip to content

Spectral Precise Image-Colon Cancer

CT Image Quality Assessment of Colon Cancer Using Spectral Precise Image Deep Learning Reconstruction

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07620444
Enrollment
100
Registered
2026-06-02
Start date
2026-06-01
Completion date
2026-12-31
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer Patients

Keywords

Spectral Precise Image

Brief summary

This is a single-center, comparative, observational study. Datasets will be collected from patients with pathologically confirmed colon cancer who undergo abdomen-pelvis enhanced spectral CT scan.

Detailed description

This is a single-center, comparative, observational study. Datasets will be collected from patients with pathologically confirmed colon cancer who undergo abdomen-pelvis enhanced spectral CT scan at investigational center, including retrospective and prospective data. Based on the Dose Right Index (DRI) derived from CT image data, relevant data will be collected at a 1:1 ratio for the conventional radiation dose group (RD group, DRI = 21) and the low radiation dose group (LD group, DRI = 18). A total of 100 cases of datasets is expected to be collected. All CT raw data will be transmitted to Philips after the completion of the de-identification process. For the three-phase data of the LD group (plain scan, arterial phase and venous phase), offline reconstruction will be performed using the Spectral Precise Image algorithm to generate conventional images and VMI-40 keV images. A total of six image sequences will be quantitatively and qualitatively evaluated and compared. For both groups, conventional images and VMI-40 keV images will be reconstructed using iDose4.

Interventions

DEVICEThis is an observational study

This is an observational study

Sponsors

Philips Clinical & Medical Affairs Global
Lead SponsorINDUSTRY
Sun Yat-Sen University Cancer Center
CollaboratorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Patients pathologically confirmed with colon cancer via endoscopic biopsy. 2. Patients who underwent preoperative abdominopelvic enhanced spectral CT. 3. Study participant with age ≥ 18 years old. 4. Study participants that have signed Informed Consent Form (ICF).

Exclusion criteria

1. The clinical data or pathological information is considered incomplete after evaluation by the investigator. 2. The investigator determined that poor image quality (e.g. obvious artifacts, missing critical scan layers) would not satisfy post-processing analysis. 3. Data of patients deemed inappropriate for inclusion after evaluation by the investigator.

Design outcomes

Primary

MeasureTime frameDescription
subjective overall Image quality using 5-point Likert scale(1-5)From the date of image reconstruction completion to the date of image evaluation completion, anticipated 3 Months.Radiologist will evaluate the overall image quality using 5 Likert scale ranging from 1(poor) to 5 (Excellent)
Objective image qualityFrom the date reconstruction completion to the date of image evaluation completion, anticipated 3months.The objective image quality is evaluated by measuring the CT value shown in the image.

Countries

China

Contacts

CONTACTMiao Chuan Xie
xiechm@sysucc.org.cn+8618903050011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026